Menu

Clarivate Ranks Most-Cited Researchers of 2017

China shows the biggest increase of any country in the number of scientists listed since last year, while cancer genomics emerges as one of the more dominant fields.

Nov 15, 2017
Catherine Offord

ISTOCK, MATJAZ SLANICAround half of the world’s “Highly Cited Researchers” are based in the U.S., with the U.K. and China taking second and third place, respectively, according to a new report by Clarivate Analytics.

The list was assembled on the basis of authors’ recent production of “Highly Cited Papers”—those that have enough citations to be ranked in the top 1 percent of articles published in the same year and field. By this ranking system, the U.S. has 1,644 highly cited authors—a 12 percent increase since last year. China currently has 249 highly cited authors—a jump of more than 40 percent since last year, and the largest increase of any nation.

“The rise of China in publication output and world share in internationally influential journals indexed in the Web of Science has been a dramatic development during the last 20 years,” David Pendlebury, senior citations analyst at Clarivate Analytics, says in a statement. “In some fields China has not only caught up, but it is now powering ahead.”

Clarivate has also published a list of the world’s “Hottest Researchers,” crediting individuals who have published at least 14 “Hot Papers”—papers that rapidly start accumulating citations after publication—since 2014. Researchers working in the life sciences or biotech account for 11 of the 21 entries, with the highest rank (and third place across all fields) going to the Broad Institute’s Eric Lander, a genomicist involved in the Cancer Atlas Genome Project who currently has 21 such papers.

Other “hot” life scientists include MIT’s Feng Zhang—one of the pioneers of CRISPR-Cas9 genome editing—and cancer researcher Caroline Robert of the Institut Gustave Roussy in Villejuif, France, whose work has included trials of anticancer therapeutics such as the melanoma drug nivolumab.

(Hat tip to Times Higher Education)

August 2018

Conscious Rodents?

The complex ethics of transplanting human brain organoids into rats and mice

Marketplace

Sponsored Product Updates

New Compact Refrigerators Designed for Secure and Sustainable Clinical Storage

New Compact Refrigerators Designed for Secure and Sustainable Clinical Storage

A new series of compact refrigerators has been specifically developed to address the need of clinical laboratories and patient care facilities for cold storage equipment that enable secure and energy-efficient storage of vaccines, medicines, lab kits and breast milk, while offering quiet operation and a small footprint.

New 25 ml divided reservoir offers lowest dead volume on the market

New 25 ml divided reservoir offers lowest dead volume on the market

INTEGRA has expanded its Clear Advantage™ product family to include a divided reservoir, offering 5 and 10 ml volumes side-by-side, while still nesting comfortably in the company’s standard 25 ml reusable, sturdy base. A combination of design and innovation offers a pipetting experience with less reagent and plastic waste, and the lowest dead volume on the market.

BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio

BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio

BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.

New England Biolabs® Launches NEBNext Direct® Custom Ready Panels for Efficient Targeted Re-sequencing

New England Biolabs® Launches NEBNext Direct® Custom Ready Panels for Efficient Targeted Re-sequencing

New England Biolabs (NEB®) today announced the launch of the NEBNext Direct Custom Ready Panels. The new panels — coupled with the proprietary NEBNext Direct target enrichment technology — enable the rapid development and deployment of a customized target enrichment panel by allowing users to select from an extensive library of genes to produce sequencing data with high specificity and coverage uniformity.